| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446979 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
In this exploratory sub-analysis in AVADO, bevacizumab plus docetaxel showed efficacy in elderly patients similar to the overall study population. There were no unexpected safety signals in patients aged 65Â years or older.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xavier Pivot, Andreas Schneeweiss, Shailendra Verma, Christoph Thomssen, José Luis Passos-Coelho, Giovanni Benedetti, Eva Ciruelos, Roger von Moos, Hong-Tai Chang, Anja-Alexandra Duenne, David W. Miles,